Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Vancomycin
Phase II study of the efficacy and safety of oral GD0039 in patients with locally advanced or metastatic renal cell carcinoma.
Psychiatric comorbidity in adolescent electronic and conventional cigarette use.
131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II study.
Mechanistic and pharmacologic insights on immune checkpoint inhibitors.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Mechanistic and pharmacologic insights on immune checkpoint inhibitors.
Mechanistic and pharmacologic insights on immune checkpoint inhibitors. Pharmacol Res. 2017 Jun; 120:1-9.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
CTLA-4 Antigen
Humans
Immunity
Immunotherapy
Ipilimumab
Neoplasms
Programmed Cell Death 1 Receptor
authors with profiles
Randy Sweis